Cargando…
Active immunization with norovirus P particle-based amyloid-β chimeric protein vaccine induces high titers of anti-Aβ antibodies in mice
BACKGROUND: Active immunotherapy targeting amyloid-β (Aβ) is a promising treatment for Alzheimer’s disease (AD). Numerous preclinical studies and clinical trials demonstrated that a safe and effective AD vaccine should induce high titers of anti-Aβ antibodies while avoiding the activation of T cells...
Autores principales: | Yang, Ping, Guo, Yongqing, Sun, Yao, Yu, Bin, Zhang, Haihong, Wu, Jiaxin, Yu, Xianghui, Wu, Hui, Kong, Wei |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6373079/ https://www.ncbi.nlm.nih.gov/pubmed/30755174 http://dx.doi.org/10.1186/s12865-019-0289-9 |
Ejemplares similares
-
Norovirus P particle-based active Aβ immunotherapy elicits sufficient immunogenicity and improves cognitive capacity in a mouse model of Alzheimer’s disease
por: Fu, Lu, et al.
Publicado: (2017) -
Norovirus P particle-based tau vaccine-generated phosphorylated tau antibodies markedly ameliorate tau pathology and improve behavioral deficits in mouse model of Alzheimer’s disease
por: Sun, Yao, et al.
Publicado: (2021) -
Correction to: Norovirus P particle-based tau vaccine-generated phosphorylated tau antibodies markedly ameliorate tau pathology and improve behavioral deficits in mouse model of Alzheimer’s disease
por: Sun, Yao, et al.
Publicado: (2021) -
Interaction between hexon and L4-100K determines virus rescue and growth of hexon-chimeric recombinant Ad5 vectors
por: Yan, Jingyi, et al.
Publicado: (2016) -
Anti-Aβ Antibodies and Cerebral Amyloid Angiopathy Complications
por: Chantran, Yannick, et al.
Publicado: (2019)